BioCatalyst

Azacitidine, IMGN632, Venetoclax — catalyst calendar

1 verified catalyst event(s) referencing Azacitidine, IMGN632, Venetoclax, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants Wi
Phase 1/2 · Acute Myeloid Leukemia
 ABBV AbbVie Inc. Azacitidine, IMGN632, Venetoclax ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.